Novartis | NVS - Current Assets

Stock Price
151.02
Daily Change
2.33 1.57%
Monthly
9.50%
Yearly
44.32%
Q1 Forecast
145.07

Novartis reported $28.2B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Amgen USD 27.88B 1.15B Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
Bausch Health Companies USD 6.25B 265M Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Glaxosmithkline GBP 23.98B 6.31B Sep/2025
J&J USD 54.61B 113M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Prestige Brands USD 497.41M 16.89M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Zoetis USD 6.58B 660M Sep/2025